← FDA Drug Approvals (Drugs@FDA)

FLUDEOXYGLUCOSE F18

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MCPRF · Approved 2013-08-05

Drug application

FDA Application #

ANDA203612

Application type

Abbreviated New Drug Application (Generic)

Brand name

FLUDEOXYGLUCOSE F18

Generic name

FLUDEOXYGLUCOSE F-18

Active ingredients

FLUDEOXYGLUCOSE F-18

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MCPRF

Manufacturer

Mayo Clinic

First approval

2013-08-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown